Hippocampal synapsin I, growth-associated protein-43, and microtubule-associated protein-2 immunoreactivity in learned helplessness rats and antidepressant-treated rats

Neuroscience

Volumn 141, Issue 3, 2006, Pages 1301-1313

  Iwata, M ^a   Shirayama, Y ^a   Ishida, H ^a   Kawahara, R ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

depression; growth associated protein 43; hippocampus; learned helplessness; microtubule associated protein 2; synapsin I

Indexed keywords

ANTIDEPRESSANT AGENT; FLUVOXAMINE; IMIPRAMINE; MICROTUBULE ASSOCIATED PROTEIN 2; NEUROMODULIN; SYNAPSIN I;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CONTROLLED STUDY; DEPRESSION; HIPPOCAMPUS; IMMUNOREACTIVITY; LEARNED HELPLESSNESS; NERVE CELL PLASTICITY; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STATISTICAL SIGNIFICANCE;

ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; FLUVOXAMINE; GAP-43 PROTEIN; HELPLESSNESS, LEARNED; HIPPOCAMPUS; IMIPRAMINE; IMMUNOHISTOCHEMISTRY; MALE; MICROTUBULE-ASSOCIATED PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; SYNAPSINS; TIME FACTORS;

EID: 33746433483     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.04.060     Document Type: Article

References (72)

1. Alfarez D.N., Joëls M., and Krugers H.J. Chronic unpredictable stress impairs long-term potentiation in rat hippocampal CA1 area and dentate gyrus in vitro. Eur J Neurosci 17 (2003) 1928-1934
2. Altar C.A. Neurotrophins and depression. Trends Pharmacol Sci 20 (1999) 59-61
3. Aoki C., and Siekevitz P. Ontogenetic changes in the cyclic adenosine 3′,5′-monophosphate-stimulatable phosphorylation of cat visual cortex proteins, particularly of microtubule-associated protein 2 (MAP 2). effects of normal and dark rearing and of the exposure to light. J Neurosci 5 (1985) 2465-2483
4. Benowitz L.I., and Routtenberg. A GAP-43. an intrinsic determinant of neuronal development and plasticity. Trends Neurosci 20 (1997) 84-91
5. Bremner J., Narayan M., Anderson E.R., Staib L.H., Miller H., and Charney D.S. Smaller hippocampal volume in major depression. Am J Psychiatry 157 (2000) 115-117
6. Buddle M., Eberhardt E., Ciminello L.H., Levin T., Wing R., DiPasquale K., and Raley-Susman K.M. Microtubule-associated protein 2 (MAP2) associates with the NMDA receptor and is spatially redistributed within rat hippocampal neurons after oxygen-glucose deprivation. Brain Res 978 (2003) 38-50
7. Castren E. Is mood chemistry?. Nat Rev Neurosci 6 (2005) 241-246
8. Caceres A., Payne M.R., Binder L.I., and Steward O. Immunocytochemical localization of actin and microtubule-associated protein MAP2 in dendritic spines. Proc Natl Acad Sci U S A 80 (1983) 1738-1742
9. Chambers J.S., Thomas D., Saland L., Neve R.L., and Perrone-Bizzozero N.I. Growth-associated protein 43 (GAP-43) and synaptophysin alterations in the dentate gyrus of patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 29 (2005) 283-290
10. Chen B., Wang J.F., Sun X., and Young L.T. Regulation of GAP-43 expression by chronic desipramine treatment in rat cultured hippocampal cells. Biol Psychiatry 53 (2003) 530-537
11. Cotter D., Wilson S., Roberts E., Kerwin R., and Everall I.P. Increased dendritic MAP2 expression in the hippocampus in schizophrenia. Schizophr Res 41 (2000) 313-323
12. DeCamilli P., Cameron R., and Greengard P. Synapsin I (protein I), a nerve terminal-specific phosphoprotein. I. Its general distribution is synapses of the central and peripheral nervous system demonstrated by immunofluorescence in frozen and plastic sections. J Cell Biol 96 (1983) 1337-1354
13. Dekker L.V., De Graan P.N., Oestreicher A.B., Versteeg D.H., and Gispen W.H. Inhibition of noradrenaline release by antibodies to B-50 (GAP-43). Nature 342 (1989) 74-76
14. Duman R.S. Synaptic plasticity and mood disorders. Molecular Psychiatry 7 (2002) S29-S34
15. Duman R.S., Heninger G.R., and Nestler E.J. A molecular and cellular theory of depression. Arch Gen Psychiatry 54 (1997) 597-606
16. Duman R.S., Nakagawa S., and Malberg J. Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology 25 (2001) 836-844
17. Eastwood S.L., and Harrison P.J. Hippocampal and cortical growth-associated protein-43 messenger RNA in schizophrenia. Neuroscience 86 (1998) 437-448
18. Eastwood S.L., and Harrison P.J. Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins. Brain Res Bull 55 (2001) 569-578
19. Eichenbaum H., Schoenbaum G., Young B., and Bunsey M. Functional organization of the hippocampal memory system. Proc Natl Acad Sci U S A 93 (1996) 13500-13507
20. Ferreira A., and Rapoport M. The synapsins. beyond the regulation of neurotransmitter release. Cell Mol Life Sci 59 (2002) 589-595
21. Greengard P., Valtorta F., Czernik A.J., and Benfenati F. Synaptic vesicle phosphoproteins and regulation of synaptic function. Science 259 (1993) 780-785
22. Harrison P.J. The neuropathology of primary mood disorder. Brain 125 (2002) 1428-1449
23. Houser C.R. Neuronal loss and synaptic reorganization in temporal lobe epilepsy. Adv Neurol 79 (1999) 743-761
24. Hrdina P., Faludi G., Li Q., Bendotti C., Tekes K., Sotonyi P., and Palkovits M. Growth-associated protein (GAP-43), its mRNA, and protein kinase C (PKC) isoenzymes in brain regions of depressed suicides. Mol Psychiatry 3 (1998) 411-418
25. Huot R.L., Plotsky P.M., Lenox R.H., and McNamara R.K. Neonatal maternal separation reduces hippocampal mossy fiber density in adult Long Evans rats. Brain Res 950 (2002) 52-63
26. Ishida H., Shirayama Y., Iwata M., and Kawahara R. Subchronic treatment with imipramine ameliorates the decreased number in neuropeptide Y-positive cells in the hippocampus of learned helplessness rats. Brain Res 1046 (2005) 239-243
27. Iwata S., Hewlett G.H.K., Ferrell S.T., Czernik A.J., Meiri K.F., and Gnegy M.E. Increased in vivo phosphorylation state of neuromodulin and synapsin I in striatum from rats treated with repeated amphetamine. J Pharmacol Exp Ther 278 (1996) 1428-1434
28. Jacobs B.L., Praag H., and Gage F.H. Adult brain neurogenesis and psychiatry. a novel theory of depression. Mol Psychiatry 5 (2000) 262-269
29. Johnson G.V., and Jope R.S. The role of microtubule-associated protein 2 (MAP 2) in neuronal growth, plasticity, and degeneration. J Neurosci Res 33 (1992) 505-512
30. Jovanovic J.N., Czernik A.J., Fienberg A.A., Greengard P., and Sihra T.S. Synapsins as mediators of BDNF-enhanced neurotransmitter release. Nat Neurosci 3 (2000) 323-329
31. Jung Y.J., Park S.J., Park J.S., and Lee K.E. Glucose/oxygen deprivation induces the alteration of synapsin I and phosphorylation. Brain Res 996 (2004) 47-54
32. Khuchua Z., Wozniak D.F., Bardgett M.E., Yue Z., McDonald M., Boero J., Hartman R.E., Sims H., and Strauss A.W. Deletion of the N-terminus of murine map2 by gene targeting disrupts hippocampal ca1 neuron architecture and alters contextual memory. Neuroscience 119 (2003) 101-111
33. Kosik K.S., and Finch E.A. MAP2 and tau segregate into dendritic and axonal domains after the elaboration of morphologically distinct neurites. an immunocytochemical study of cultured rat cerebrum. J Neurosci 7 (1987) 3142-3153
34. Kuroda Y., and McEwen B.S. Effect of chronic restraint stress and tianeptine on growth factors, growth-associated protein-43 and microtubule-associated protein 2 mRNA expression in the rat hippocampus. Brain Res Mol Brain Res 59 (1998) 35-39
35. Marti E., Ferrer I., and Blasi J. Transient increase of synapsin-I immunoreactivity in the mossy fiber layer of the hippocampus after transient forebrain ischemia in the Mongolian gerbil. Brain Res 824 (1999) 153-160
36. Martin J.V., Edwards E., Johnson J.O., and Henn F.A. Monoamine receptors in an animal model of affective disorder. J Neurochem 55 (1990) 1142-1148
37. Mazer C., Muneyyirci J., Taheny K., Raio N., Borella A., and Whitaker-Azmitia P. Serotonin depletion during synaptogenesis leads to decreased synaptic density and learning deficits in the adult rat. a possible model of neurodevelopmental disorders with cognitive deficits. Brain Res 760 (1997) 68-73
38. McEwen B.S. Stress and hippocampal plasticity. Annu Rev Neurosci 22 (1999) 105-122
39. Meiri K.F., Saffell J.L., Walsh F.S., and Doherty P. Neurite outgrowth stimulated by neural cell adhesion molecules requires growth-associated protein-43 (GAP-43) function and is associated with GAP-43 phosphorylation in growth cones. J Neurosci 18 (1998) 10429-10437
40. Miyamoto S., Asakura M., Sasuga Y., Osada K., Bodaiji N., Imafuku J., and Aoba A. Effects of long-term treatment with desipramine on microtubule proteins in rat cerebral cortex. Eur J Pharmacol 333 (1997) 279-287
41. Monnerie H., Shashidhara S., and Le Roux P.D. Effect of excess extracellular glutamate on dendrite growth from cerebral cortical neurons at 3 days in vitro. involvement of NMDA receptors. J Neurosci Res 74 (2003) 688-700
42. 2 receptor-mediated behavior 11 days after shock in learned helplessness rats. Eur J Pharmacol 281 (1995) 123-130
43. Pilc A., Branski P., Palucha A., and Aronowski J. The effect of prolonged imipramine and electroconvulsive shock treatment on calcium/calmodulin-dependent protein kinase II in the hippocampus of rat brain. Neuropharmacology 38 (1999) 597-603
44. Ramirez-Amaya V., Balderas I., Sandoval J., Escobar M.L., and Bermudez-Rattoni F. Spatial long-term memory is related to mossy fiber synaptogenesis. J Neurosci 21 (2001) 7340-7348
45. Rapp S., Baader M., Hu M., Jennen-Steinmetz C., and Thome J. Differential regulation of synaptic vesicle proteins by antidepressant drugs. Pharmacogenomics J 4 (2004) 110-113
46. Rekart J.L., Meiri K., and Routtenberg A. Hippocampal-dependent memory is impaired in heterozygous GAP-43 knockout mice. Hippocampus 15 (2005) 1-7
47. Rekart J.L., Quinn B., Mesulam M.M., and Routtenberg A. Subfield-specific increase in brain growth protein in postmortem hippocampus of Alzheimer's patients. Neuroscience 126 (2004) 579-584
48. Riedel W.J., Klaassen T., Griez E., Honig A., Menheere P.P.C.A., and van Praag H.M. Dissociable hormonal, cognitive and mood responses to neuroendocrine challenge. evidence for receptor-specific serotonergic dysregulation in depressed mood. Neuropsychopharmacology 26 (2002) 358-367
49. Sapolsky R.M. The possibility of neurotoxicity in the hippocampus in major depression. a primer on neuron death. Biol Psychiatry 48 (2000) 755-765
50. Sato K., Morimoto K., Suematu S., Sato T., and Yamada N. Increased synapsin I immunoreactivity during long-term potentiation in rat hippocampus. Brain Res 872 (2000) 219-222
51. Seligman M.E., and Beagley G. Learned helplessness in the rat. J Comp Physiol Psychol 88 (1975) 534-541
52. Sheline Y.I., Wang P.W., Gado M.H., Csernansky J.G., and Vannier M.W. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A 93 (1996) 3908-3913
53. Shirayama Y., Chen A.C., Nakagawa S., Russell D.S., and Duman R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 22 (2002) 3251-3261
54. Shirayama Y., Ishida H., Iwata M., Hazama G., Kawahara R., and Duman R.S. Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects. J Neurochem 90 (2004) 1258-1268
55. Shors T.J., Seib T.B., Levine S., and Thompson R.F. Inescapable versus escapable shock modulates long-term potentiation in rat hippocampus. Science 244 (1989) 224-226
56. Shors T.J., Miesegaes G., Beylin A., Zhao M., Rydel T., and Gould E. Neurogenesis in the adult is involved in the formation of trace memories. Nature 410 (2001) 372-376
57. Skene J.H., Jacobson R.D., Snipes G.J., McGuire C.B., Norden J.J., and Freeman J.A. A protein induced during nerve growth (GAP-43) is a major component of growth-cone membranes. Science 233 (1986) 783-786
58. Skutella T., and Nitsch R. New molecules for hippocampal development. Trends Neurosci 24 (2001) 107-113
59. Smith N.A., Makino S., Kvetnansky R., and Post R.M. Stress alters the express of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 15 (1995) 1768-1777
60. Thome J., Pesold B., Baader M., Hu M., Gewirtz J.C., Duman R.S., and Henn F.A. Stress differentially regulate synaptophysin and synaptotagmin expression in hippocampus. Biol Psychiatry 50 (2001) 809-812
61. Tolner E.A., van Vliet E.A., Holtmaat A.J., Aronica E., Witter M.P., da Silva F.H., and Gorter J.A. GAP-43 mRNA and protein expression in the hippocampal and parahippocampal region during the course of epileptogenesis in rats. Eur J Neurosci 17 (2003) 2369-2380
62. Ueyama T., Kawai Y., Nemoto K., Sekimoto M., Tone S., and Senba E. Immobilization stress reduced the expression of neurotrophins and their receptors in the rat brain. Neurosci Res 28 (1997) 103-110
63. Vaidya V.A., Terwilliger R.Z., and Duman R.S. Alterations in heavy and light neurofilament proteins in hippocampus following chronic ECS administration. Synapse 35 (2000) 137-143
64. Vaillant A.R., Zanassi P., Walsh G.S., Aumont A., Alonso A., and Miller F.D. Signaling mechanisms underlying reversible, activity-dependent dendrite formation. Neuron 34 (2002) 985-998
65. Van Dijken H.H., Van der Heyden J.A., Mos J., and Tilders F.J. Inescapable footshocks induce progressive and long-lasting behavioural changes in male rats. Physiol Behav 51 (1992) 787-794
66. Vaynman S., Ying Z., and Gomez-Pinilla F. Hippocampal BDNF mediates the efficacy of exercise on synaptic plasticity and cognition. Eur J Neurosci 20 (2004) 2580-2590
67. Vollmayr B., Simonis C., Weber S., Gass P., and Henn F. Reduced cell proliferation in the dentate gyrus is not correlated with the development of learned helplessness. Biol Psychiatry 54 (2003) 1035-1040
68. Whitaker-Azmitia P.M., Borella A., and Raio N. Serotonin depletion in the adult rat causes loss of the dendritic marker MAP-2. A new animal model of schizophrenia?. Neuropsychopharmacology 12 (1995) 269-272
69. Xu H., He J., Richardson J.S., and Li X.-M. The response of synaptophysin and microtubule-associated protein 1 to restraint stress in rat hippocampus and its modulation by venlafaxine. J Neurochem 91 (2004) 1380-1388
70. Young E., Cesena T., Meiri K.F., and Perrone-Bizzozero N.I. Changes in protein kinase C (PKC) activity, isozyme translocation, and GAP-43 phosphorylation in the rat hippocampal formation after a single-trial contextual fear conditioning paradigm. Hippocampus 12 (2002) 457-464
71. Young E.A., Owen E.H., Meiri K.F., and Wehner J.M. Alterations in hippocampal GAP-43 phosphorylation and protein level following contextual fear conditioning. Brain Res 860 (2000) 95-103
72. Zink M., Rapp S., Gebicke-Haerter P.J., Henn F.A., and Thome J. Antidepressants differentially affect expression of complexin I and II RNA in rat hippocampus. Psychopharmacology 181 (2005) 560-565